Patents for A61K 49 - Preparations for testing in vivo (35,376)
02/1998
02/10/1998US5716979 Tachykinin antagonists
02/10/1998US5716642 Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
02/10/1998US5716598 Contrast medium for magnetic resonance imaging using physiologically tolerable manganese compound
02/10/1998US5716597 A site-specific liquid-liquid emulsion useful as imaging agent for ultrasonic imaging of animal, consists of water, water insoluble gas forming perfluorohydrocarbon, a stabilizer either hdrophobic or hydrophilic compound
02/10/1998US5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments
02/10/1998US5715824 Biological apparatus comprising a vessel for foaming procedure
02/10/1998CA1339666C Non-ionic polyol contrast media from ionic contrast media
02/10/1998CA1339665C Iodinated non-ionic triodobenzene compounds and contrast media containing them
02/05/1998WO1998004293A1 Improved detection and therapy of lesions with biotin-chelate conjugates
02/05/1998WO1998004292A2 Polymer-lipid microencapsulated gases for use as imaging agents
02/05/1998WO1997045145A3 A diagnostic test for schizophrenia, using niacin
02/04/1998EP0822180A1 Chelating compounds, their chelates with paramagnetic metal ions, their preparation and use
02/04/1998EP0821593A2 Conjugate of an active agent, a polyether and possibly a native protein regarded as acceptable by the body
02/04/1998CN1172436A Diagnostic imaging contrast agents with extended blood retention
02/03/1998US5714591 Gadolinium-DTPA complex containing carborane unit, intermediates thereof and method of synthesizing them
02/03/1998US5714529 Contrast media for ultrasonic imaging
02/03/1998US5714528 Contrast media for ultrasonic imaging
02/03/1998US5714166 Bioactive and/or targeted dendrimer conjugates
01/1998
01/29/1998WO1998003207A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety
01/29/1998WO1998003206A1 The butyrophilin gene promoter and uses thereof
01/29/1998WO1998003205A2 Enhanced ultrasound contrast imaging using inhaled gases
01/29/1998WO1998003159A2 Lipid-binding proteins and their therapeutic and diagnostic use
01/29/1998WO1997036619A3 Bioactivated diagnostic imaging contrast agents
01/29/1998WO1997032609A3 Microencapsulated fluorinated gases for use as imaging agents
01/29/1998CA2260253A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety
01/29/1998CA2260020A1 The butyrophilin gene promoter and uses thereof
01/29/1998CA2257524A1 Lipid-binding proteins and their therapeutic and diagnostic use
01/28/1998EP0820462A1 Cleavage of rna using metal complexes
01/28/1998EP0820432A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
01/28/1998EP0820303A1 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES
01/28/1998EP0609336B1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered
01/28/1998CN1171271A Interposition-type ultrasonic coupler and preparing process thereof
01/27/1998US5712389 Polyaminated ligands and metal complexes thereof
01/27/1998US5712370 Erythropoietin (EPO) peptides and antibodies directed against these
01/27/1998US5711933 Method of making polymeric gas or air filled microballoons for ultrasonic echography
01/27/1998US5711932 Applying to nerve cord of drosophila, cholinergic agents
01/22/1998WO1998002192A1 Radiometal-binding peptide analogues
01/21/1998EP0818989A1 Novel compositions of lipids and stabilizing materials
01/20/1998US5710010 Assays for the presence of a mutant EGF receptor
01/20/1998US5709846 Iodinated derivatives, their preparation and their use as contrast agents in x-ray radiology
01/20/1998US5709845 Tricyclic functional dyes for contrast enhancement in optical imaging
01/20/1998US5709844 Transgenic mice expressing HPV early region oncogene develop progressive cervico-vaginal neoplasia
01/15/1998WO1998001757A1 Labelling and selection of molecules
01/15/1998WO1998001555A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors
01/15/1998WO1998001163A2 Pseudopolyrotaxanes
01/15/1998WO1997032989A3 Recombinant aav vector-based transduction system and use of same
01/15/1998DE19629494A1 Pseudopolyrotaxane Pseudopolyrotaxanes
01/15/1998DE19626530A1 Aqueous magnetic resonance contrast agent compositions
01/14/1998EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
01/14/1998EP0817592A1 Process and device for determining the volume of blood circulating in a living organism
01/14/1998EP0474785B1 Percutaneous lymphography
01/14/1998EP0437488B1 Animal model for human disease
01/14/1998EP0394277B1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same
01/13/1998US5708166 Macrocyclic chelants, their chelates and uses thereof in the diagnostic field
01/13/1998US5708147 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis
01/13/1998US5707986 Angiographic method using green porphyrins in primate eyes
01/13/1998US5707844 Immunoassay reagents and methods for detecting brequinar and analogs
01/13/1998US5707813 Hybridization and amplification of target, phthalocyanine dye linked to oligonucleotides and solubilizing groups, fluorescence
01/13/1998US5707795 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
01/13/1998US5707615 Method of treating HIV infections with anti-viral formulations
01/13/1998US5707607 Dodecafluoropentane, fluorinated surfactant
01/13/1998US5707606 Phase shift colloids as ultrasound contrast agents
01/13/1998US5707605 Magnetic resonance imaging agents for the detection of physiological agents
01/13/1998US5707603 Useful in therapeutic and diagnostic imaging
01/13/1998US5706814 Method of determining a position of a probe relative to a tooth using MRI
01/08/1998WO1998000560A2 Method for determining lymphocyte distribution and trafficking in mammals using imaging
01/08/1998WO1998000535A2 Method for inhibiting hiv-1 infection, drug screens, and methods of diagnosis and prognosis of susceptibility to hiv infection
01/08/1998WO1998000172A2 Compositions and methods for altering the biodistribution of biological agents
01/08/1998DE19725817A1 Ultrasonic imaging and prodn. of US waves by excitation of contrast material
01/08/1998DE19627309A1 Aqueous injectable contrast agent for X=ray, MRI etc.
01/07/1998EP0815234A1 Proteinase k resistant surface protein of neisseria meningitidis
01/07/1998EP0815072A1 Radiographic contrasting agent for computerised tomography and urography
01/07/1998EP0814849A1 Magnetically labeled chemoattractants as targeted contrast agents in the nmr imaging of living tissues
01/07/1998EP0814848A1 Microparticles, agents containing said microparticles for use in ultrasound diagnostics, and processes for producing said particles and agents
01/07/1998EP0814847A1 Methods and compositions for in-vivo detection of oral cancers and precancerous conditions
01/07/1998EP0486572B1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
01/07/1998EP0447424B1 Isolation of fetal cells from maternal blood to enable prenatal diagnosis
01/06/1998US5705187 Compositions of lipids and stabilizing materials
01/06/1998US5705158 Kits with antileukocyte antibody conjugates
01/06/1998US5705153 Glucocerebrosidase conjugate and polyoxyalkylene oxide strands
01/06/1998US5704369 Non-invasive method for diagnosing Alzeheimer's disease in a patient
01/06/1998US5704358 Method and apparatus for diagnosing capillary leak
01/06/1998CA2002917C Fluorescent indicator dyes for alkali metal cations
01/02/1998DE19624426A1 Magnetic particle for transport of diagnostic or therapeutic agent
12/1997
12/31/1997WO1997049433A1 Fluoro labelled anthracyclinone and anthracycline derivatives
12/31/1997CA2258630A1 Fluoro labelled anthracyclinone and anthracycline derivatives for treatment and diagnosis of amyloidosis
12/30/1997US5703126 Amphiphilic fluorine derivatives with telomeric structures
12/30/1997US5702722 Three-dimensional expanded structure; drug delivery
12/30/1997US5702683 Nuclear magnetic resonance contrast agents
12/30/1997US5702682 Soaking the medical equipment containing cation salt of an anionic polymer containing carboxylate or sulfate, in aqueous solution of metal cations to replace atleast portion of cation to form water insoluble cationic polymer
12/30/1997US5702681 Method for detecting flukicidal activity
12/30/1997US5702361 Method for embolizing blood vessels
12/30/1997US5701899 Perfluorobutane ultrasound contrast agent and methods for its manufacture and use
12/29/1997EP0813523A2 Preparation of n-arylmethyl aziridine derivatives, 1,4,7,10-tetraazacyclododecane derivatives obtained therefrom and n-arylmethyl-ethanol-amine sulphonate esters as intermediates
12/29/1997EP0543020B1 Oxidized composite comprising water-soluble carboxypolysaccharide and magnetic iron oxide
12/24/1997WO1997048792A1 Transgenic non-human mammals with progressive neurologic disease
12/24/1997WO1997048337A1 Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent
12/24/1997CN1168636A Liposomal agents
12/23/1997US5700649 Method of detection of urinary tumor associated antigen
12/23/1997US5700459 Polybase and polyacid, one of which is a polymer, active material comprising antiinflammatory agent, antibiotic, enzyme inhibitor